
BIO KEY INTERNATIONAL INC
100
Recent news coverage includes general market updates and specific business developments related to BIO-key's partnerships and contracts in Europe and India.
- BIO-key's EMEA subsidiary partnered with Citadel Global to expand presence in India and accelerate adoption of biometric identity solutions in support of the EU–India Free Trade Agreement [N1].
- BIO-key and Visualforma were awarded a contract to secure digital identities for a large municipality in Portugal [N2].
- Recent market news includes reports on commodity trading and geopolitical developments, which are not directly related to BIO-key's business [N3][N4][N5][N6][N7][N8].
BIO-key International, Inc. develops and markets advanced biometric identity and access management (IAM) solutions designed to enable secure, passwordless multi-factor authentication (MFA) for workforce, customer, citizen, and student access. Its flagship product, PortalGuard, is offered both as on-premise software and as a cloud-based Identity-as-a-Service (IDaaS) platform, integrating server-secured Identity-Bound Biometrics (IBB) and supporting multiple authentication factors, user directories, and federation protocols. BIO-key also offers WEB-key biometric infrastructure for large-scale civil ID projects, MobileAuth mobile authentication apps, and a line of fingerprint scanners compliant with industry security standards. The company targets enterprise, government, education, and regulated industries, emphasizing solutions for users who cannot rely on phones or tokens, such as roving or shared workstation users. BIO-key has grown through strategic acquisitions, including PistolStar and Swivel Secure Europe, and sells products directly and through a network of channel partners. The company is a Microsoft Partner and its hardware supports Windows Hello. BIO-key's business model includes SaaS subscription revenue, hardware sales, and OEM partnerships, serving over 600 customers worldwide as of 2025.
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. BIO-key International, Inc. is an identity and access management platform provider specializing in biometric multi-factor authentication solutions for enterprise, education, and government customers. The company offers a suite of products including PortalGuard IAM software, biometric hardware, and mobile authentication applications. BIO-key reported approximately $5.94 million in revenue for 2025, with a net loss of about $7.16 million, including a $2.5 million impairment expense. Cash and cash equivalents were approximately $2.69 million as of December 31, 2025, with a current ratio of 1.47. The company serves over 600 customers globally and focuses on markets such as government, healthcare, financial services, and education. BIO-key continues to expand its channel partner program and OEM customer base, while facing competition from other biometric and IAM providers.
BIO-key's advanced biometric authentication technology addresses critical gaps in mainstream MFA solutions, particularly for workforce users who cannot use phones or tokens. The company's integrated IAM platform and broad authentication factor support position it well to serve diverse enterprise, government, and education customers. Growth in demand for stronger cybersecurity measures, regulatory requirements, and remote work environments support the relevance of BIO-key's offerings. Expansion of channel partnerships and OEM agreements could enhance market penetration. Strategic acquisitions and new commercial initiatives, such as integrating biometrics into autonomous systems, may open additional revenue streams.
BIO-key faces significant competition from established biometric and IAM providers, which may limit market share growth. The company reported a net loss and impairment expense in 2025, indicating ongoing profitability challenges. Revenue declined compared to the prior year, partly due to contract renewals and changes in distribution agreements. Liquidity, while improved, remains moderate, and the company relies on financing activities to support operations. Integration risks from acquisitions and the need to scale sales and marketing efforts pose execution challenges. Market adoption of biometric MFA may be slower than anticipated, and technological advances by competitors could erode BIO-key's differentiation.
BIO-key's moat is anchored in its unique server-secured Identity-Bound Biometrics technology, which differentiates its multi-factor authentication solutions by enabling biometric authentication without reliance on phones or tokens. This addresses specific enterprise challenges such as roving users and shared workstations that mainstream MFA solutions struggle to serve effectively. The company's comprehensive IAM platform supports multiple authentication factors, user directories, and federation protocols, providing flexibility and integration capabilities valued by customers. Strategic acquisitions have expanded its customer base and geographic reach, while partnerships with major technology providers like Microsoft enhance credibility and market access. The combination of proprietary biometric technology, broad product suite, and established channel partnerships creates barriers to entry and customer switching costs.
• Profitability and Cash Flow Risk: BIO-key reported a net loss of approximately $7.16 million in 2025 and has historically required financing to support operations. The company needs to generate sufficient revenue and positive cash flow to sustain and grow its business.
• Competitive Risk: The IAM and biometric markets are competitive with multiple established players. BIO-key faces competition from companies like IDEMIA, Thales, and others, which may impact its market share and pricing power.
• Integration and Execution Risk: BIO-key has grown through acquisitions and must successfully integrate these businesses and scale its sales and marketing efforts to realize synergies and growth opportunities.
• Market Adoption Risk: Adoption of biometric MFA solutions depends on customer acceptance and regulatory environments. Slower adoption or technological shifts could affect BIO-key's growth prospects.
• Liquidity Risk: While cash and liquidity ratios improved as of December 31, 2025, the company continues to rely on financing activities and accounts receivable factoring to meet working capital needs.
Business trends: Increasing adoption of biometric MFA solutions driven by security needs and remote work challenges; expansion in government, education, and regulated industries.
Execution milestones: Integration of acquisitions (PistolStar, Swivel Secure Europe), growth of channel partner program, expansion of OEM customer base, and new commercial initiatives in biometric technology applications.
Key risks: Profitability challenges, competitive pressures, integration risks, market adoption uncertainties, and liquidity constraints.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- BIO-key International, Inc. is a leading identity and access management (IAM) platform provider focused on secure multi-factor authentication (MFA) for enterprise, education, and government customers enabling secure work-from-anywhere.
- The company offers products including PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) for enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication app, and accessory fingerprint scanners and FIDO-compliant hardware.
- BIO-key PortalGuard supports MFA, Single Sign On (SSO), and Self-Service Password Reset (SSPR) with 17 authentication factor choices including server-secured Identity-Bound Biometrics (IBB) via fingerprint scanners, palm scan, facial selfie, or voice biometric.
- PortalGuard integrates with various user directories (on-premise, hybrid, Azure AD, LDAP, IBM Domino, custom SQL) and supports multiple federation protocols (SAML, OpenID Connect, OAUTH, CAS, WS-Fed).
- The company targets workforce identity (employees, contractors, supply chain partners) and customer identity (users of web properties) with its IAM solutions.
- BIO-key's biometric technology addresses gaps in mainstream MFA solutions, especially for users who cannot use phones or tokens, such as roving users or shared workstations.
- The company has a history of strategic acquisitions including PistolStar (enterprise IAM solutions) and Swivel Secure Europe (EMEA IAM solutions).
- BIO-key sells products directly and through a network of over 85 channel partners, including resellers, integrators, and distributors.
- The company is a Microsoft Partner; its fingerprint scanners are tested and qualified to support Windows Hello and Windows Hello for Business.
- Hardware products accounted for 22% of revenue in 2025, up from 9% in 2024, with popular products including EcoID II and PIV-Pro fingerprint scanners compliant with security standards for regulated industries.
- BIO-key's 2025 revenue was approximately $5.94 million, down 14% from 2024, with decreases in license fees but increases in hardware sales and services.
- The company reported a net loss of approximately $7.16 million for 2025, increased from a net loss of $4.3 million in 2024, including a $2.5 million impairment expense.
- Cash and cash equivalents were approximately $2.69 million as of December 31, 2025, with a current ratio of 1.47 and a cash ratio of 0.87, indicating moderate liquidity.
- BIO-key's business model focuses on addressing enterprise needs unmet by mainstream MFA, prioritizing OEM customers, highly regulated industries, and expanding its channel partner program.
- The company serves customers in government, healthcare, financial services, education, and international law enforcement, with over 600 customers globally as of end 2025.
- BIO-key is actively exploring new commercial opportunities integrating biometric technology into autonomous systems and other industries.
- The company faces competition from other biometric and IAM providers including IDEMIA, Thales, NEC, and others, with differentiation based on server-secured biometric authentication.
- BIO-key uses a SaaS term license model generating annual recurring revenue primarily from multi-year subscriptions.
- The company has a factoring arrangement for accounts receivable to assist with working capital needs.
- BIO-key's 2025 operating expenses included selling, general and administrative costs of approximately $6.28 million and research and development costs of approximately $2.61 million.
- The company has approximately 42 employees, with a mix of engineering, finance, sales, and support staff.
- BIO-key's strategic focus includes expanding in enterprise MFA, large-scale ID projects, government initiatives, consumer mobile credentialing, and hardware demand from Windows Hello users.
- The company has a history of financing operations through equity and debt securities, including recent warrant exercises and secured promissory notes.
- BIO-key's products aim to reduce risks of theft, fraud, account takeover, and unauthorized sharing by providing stronger identity binding and user experience than traditional credentialing systems.
Generated 2026-06-12
- S1 | 2026-06-12 | 10-K
- N1 | 2026-06-12 | www.nasdaq.com | Cattle Showing Friday Losses | https://www.nasdaq.com/articles/cattle-showing-friday-losses
- N2 | 2026-06-12 | www.nasdaq.com | Hogs Trading with Friday Gains | https://www.nasdaq.com/articles/hogs-trading-friday-gains
- N3 | 2026-06-12 | www.nasdaq.com | Stocks See Support from Hopes for a Near-term US-Iran Agreement | https://www.nasdaq.com/articles/stocks-see-support-hopes-near-term-us-iran-agreement
- N4 | 2026-06-12 | www.nasdaq.com | Stocks See Support from Hopes for a Near-term US-Iran Peace Agreement | https://www.nasdaq.com/articles/stocks-see-support-hopes-near-term-us-iran-peace-agreement
- N5 | 2026-06-12 | www.nasdaq.com | Crude Oil Plunges Amid Prospects Of U.S.-Iran Deal, Reopening Of Hormuz Strait | https://www.nasdaq.com/articles/crude-oil-plunges-amid-prospects-us-iran-deal-reopening-hormuz-strait
- N6 | 2026-06-12 | www.nasdaq.com | Johnson & Johnson Just Paid $1 Billion for a Technology That Could Crack One of Cancer's Most "Undruggable" Targets. Why That's Very Good News for Investors. | https://www.nasdaq.com/articles/johnson-johnson-just-paid-1-billion-technology-could-crack-one-cancers-most-undruggable
- N7 | 2026-06-12 | www.nasdaq.com | Wheat Posting Mixed Midday Trade | https://www.nasdaq.com/articles/wheat-posting-mixed-midday-trade
- N8 | 2026-06-12 | www.nasdaq.com | Soybean Weakness Holding On Friday | https://www.nasdaq.com/articles/soybean-weakness-holding-friday
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


